{"id":"W2025016054","doi":"10.1007/s10456-014-9420-y","title":"Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions","year":2014,"lang":"en","type":"review","venue":"Angiogenesis","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":736,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust","keywords":"Bevacizumab; Sunitinib; Medicine; Vascular endothelial growth factor; Angiogenesis; Aflibercept; Cancer research; Targeted therapy; Disease; Vascular endothelial growth factor A; Oncology; VEGF receptors; Chemotherapy; Cancer; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002059011,0.0006279119,0.001167145,0.0001629891,0.000338176,0.00006526632,0.0003221911,0.0005473285,0.00002862597],"category_scores_gemma":[0.00001416651,0.0005125412,0.001598134,0.0003037663,0.0001522307,0.000005147954,0.0001051436,0.00008382623,0.000007205228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004406011,"about_ca_system_score_gemma":0.0003577304,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003238,"about_ca_topic_score_gemma":0.00005574445,"domain_scores_codex":[0.9978247,0.000143723,0.0004918481,0.000915517,0.0001452831,0.0004788911],"domain_scores_gemma":[0.9986451,0.0000409506,0.0003377016,0.000618142,0.0001860081,0.0001720936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001151562,0.00007346243,0.0002914646,0.00151737,0.0007661022,3.961661e-7,0.000008366323,3.920377e-7,0.00004574866,0.00007094732,0.006859662,0.9903546],"study_design_scores_gemma":[0.0002673456,0.0001167005,0.0001891282,0.0007756781,0.001153694,0.00001565341,0.000004612226,0.000002173531,0.0001027914,0.000009960119,0.9967414,0.00062083],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001499346,0.9960989,0.0002368321,0.0001340594,0.001202269,0.001340967,0.0007713626,0.00004962944,0.00001598442],"genre_scores_gemma":[0.00005294438,0.9895867,0.000310969,0.00007490061,0.005545209,0.003033003,0.001051888,0.0001602422,0.0001842068],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9898818,"threshold_uncertainty_score":0.9997326,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02999075197384412,"score_gpt":0.3550435051925295,"score_spread":0.3250527532186854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}